Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Grant/Award of 13,562 AVBP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 13,562 | n/a |
| May 28, 2026 | Immunocore Holdings plc (IMCR) | Grant/Award | 27,492 | n/a |
| Mar 13, 2026 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 20,000 | n/a |
| Jun 20, 2025 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 15,502 | n/a |
| May 19, 2025 | Immunocore Holdings plc (IMCR) | Grant/Award | 26,198 | n/a |
| Mar 14, 2025 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 15,700 | n/a |
| May 28, 2024 | Immunocore Holdings plc (IMCR) | Grant/Award | 14,534 | n/a |
| Apr 23, 2024 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 28,587 | n/a |
| Mar 8, 2024 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 15,700 | n/a |
| Feb 12, 2024 | ImmunoGen, Inc. (IMGN) | Disposition to Issuer | 13,090 | n/a |